Synthetic introns enable splicing factor mutation-dependent targeting of cancer cells

Many cancers carry recurrent, change-of-function mutations affecting RNA splicing factors. Here, we describe a method to harness this abnormal splicing activity to drive splicing factor mutation-dependent gene expression to selectively eliminate tumor cells. We engineered synthetic introns that were...

Descripción completa

Detalles Bibliográficos
Autores principales: North, Khrystyna, Benbarche, Salima, Liu, Bo, Pangallo, Joseph, Chen, Sisi, Stahl, Maximilian, Bewersdorf, Jan Philipp, Stanley, Robert F., Erickson, Caroline, Cho, Hana, Pineda, Jose Mario Bello, Thomas, James D., Polaski, Jacob T., Belleville, Andrea E., Gabel, Austin M., Udy, Dylan B., Humbert, Olivier, Kiem, Hans-Peter, Abdel-Wahab, Omar, Bradley, Robert K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288984/
https://www.ncbi.nlm.nih.gov/pubmed/35241838
http://dx.doi.org/10.1038/s41587-022-01224-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288984/
https://www.ncbi.nlm.nih.gov/pubmed/35241838
http://dx.doi.org/10.1038/s41587-022-01224-2

Ejemplares similares